By Craig Newton

Kynetyka is delighted to announce that the European Patent Office has granted the DVTect patent, with receipt of the Letters Patent Certificate for “A screening test for detection of deep vein thrombosis.” The patent states: “The present invention relates to systems and apparatus for assisting healthcare workers in the screening…

By Craig Newton

28 July 2025: Kynetyka is delighted to announce that it has secured funding of $500,000 from AusHealth, an Australian medical research charity. This investment will support the development of DVTect®, by funding a clinical study at the Royal Adelaide Hospital and software development by Adelaide-based HeartAI. Working in close partnership,…

By Craig Newton

Kynetyka is delighted to welcome Peter Bradley to Kynetyka as Chief Operating Officer. Peter brings an incredible wealth of experience as a medtech developer and international commercialisation executive. He will take on responsibility for further developing Kynetyka’s DVTect® medical device, overseeing the work done by Kynetyka’s engineering and clinical partners. His…

By Craig Newton

February 2022; Melbourne Australia: Kynetyka Technologies Pty Ltd (“Kynetyka”), a privately held Melbourne-based medical device company is pleased to announce that the New Zealand patent for its DVTect™ technology has been granted. To read more, click here

By Craig Newton

August 2021; Melbourne Australia: Kynetyka Technologies Pty Ltd (“Kynetyka”), a privately held Melbourne-based medical device company is delighted to announce that the USA patent for its DVTect™ technology has been granted. The patent “A screening test for detection of deep vein thrombosis” was granted on 3 August 2021, with a…